Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Shanghai YingLi Pharmaceutical Co. Ltd..
Real, source-linked trial activity for Shanghai YingLi Pharmaceutical Co. Ltd.: 1 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 30, 2026. Source-linked, daily-refreshed.
PHASE1 1
Newest Shanghai YingLi Pharmaceutical Co. Ltd. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | First-in-Human, Multicenter, Phase I Study to Evaluate Safety, Tolerab | Ph 1 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Shanghai YingLi Pharmaceutical Co. Ltd. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.